Compare CVS Health Corp (CVS) vs Mondaycom Ltd (MNDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Mondaycom Ltd — how do they compare? CVS Health Corp trades at $85.46 (market cap $112.29B), while Mondaycom Ltd trades at $88.82 (market cap $3.76B). The key difference: CVS Health Corp is far larger — about 29.9× Mondaycom Ltd's market cap, and CVS Health Corp pays a 3.03% dividend while Mondaycom Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Mondaycom Ltd for 16 Days on average.
| CVS | MNDY | |
|---|---|---|
Market Cap | $112.29B | $3.76B |
Volume | 7,763,676 | 836,200 |
Sector | Health | Technology |
52-Week High | $110.60 | $205.24 |
52-Week Low | $70.08 | $58.81 |
Typical Hold Time | 83 Days | 16 Days |
Enterprise Value | $174.64B | $2.92B |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
MNDY trades at $83.51, down 0.93% on the day, with technical indicators showing a bearish trend despite recent earnings beats. The company maintains strong profitability with 88.74% gross margins and has exceeded EPS expectations for three consecutive quarters. Recent news highlights inclusion in growth stock lists and positive analyst sentiment, while the upcoming Q3 2026 earnings report (expected EPS $1.37) will be a key catalyst.
The outlook remains positive with 65% analyst buy ratings and a $110.42 consensus price target suggesting 32% upside potential. Risks include elevated valuation multiples (P/E 37.69), competitive pressures from enterprise software rivals, and the technical bearish signal. Strong enterprise customer growth and AI integration through the Elevate '26 conference provide growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →
